Medicine
Anoro Ellipta 62.5 mcg/25 mcg inhalation powder
Anoro Ellipta 62.5 mcg/25 mcg inhalation powder is a prescription medicine containing Umeclidinium and Vilanterol for inhalation use, marketed by GlaxoSmithKline, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature between 68°F and 77°F (20°C and 25°C), excursions…
Key facts
- Active ingredient (INN)
- Umeclidinium and Vilanterol
- Brand
- Anoro Ellipta
- Strength
- 62.5 mcg/25 mcg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 1 tray
- Marketing authorisation holder
- GlaxoSmithKline
- Manufacturer
- GlaxoSmithKline
- Origin register
- US FDA, United States
- Storage
- Store at room temperature between 68°F and 77°F (20°C and 25°C), excursions permitted from 59°F to 86°F (15°C to 30°C). Store in a dry place away from direct heat or sunlight. ANORO ELLIPTA should be stored inside the unopened moisture-protective foil tray and only removed from the tray immediately before initial use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03AL03 Umeclidinium and Vilanterol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 2014
- Identifiers
- RxCUI 1487519, 1487524, 1487527 +1DailyMed set ID 2dbd0671-c565-40c5-bf0f-e324db26799cNDC 0173-0869Application NDA203975
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tray in 1 carton / 1 inhaler in 1 tray / 7 powder in 1 inhaler | 0173-0869-06 | GlaxoSmithKline | 31 January 2014 |
| 1 tray in 1 carton / 1 inhaler in 1 tray / 30 powder in 1 inhaler | 0173-0869-10 | GlaxoSmithKline | 31 January 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Umeclidinium and Vilanterol 62.5 mcg/25 mcg inhalation powder.
Clinical summary
Umeclidinium and Vilanterol is a fixed-dose combination of an anticholinergic and a beta2-adrenergic agonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), among other approved uses. MedsAcross supplies Umeclidinium and Vilanterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Umeclidinium and VilanterolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Umeclidinium and Vilanterol Ellipta prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
- Anoro Ellipta (previously Anoro): European public assessment report (EPAR) · European Medicines Agency
- Laventair Ellipta (previously Laventair): European public assessment report (EPAR) · European Medicines Agency
Need Anoro Ellipta 62.5 mcg/25 mcg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.